Honored to be selected as the inaugural fellow for the Mayo Clinic - Cardiovascular Research Foundation Innovation Mentorship Program. Grateful for @adnanalkhouli and @jgranadacrf for the opportunity to learn from leaders in MedTech innovation🫀 @MayoClinicCV @crfheart

In Interventional Cardiology, the Cath lab is identity. But the arc of every career demands a transition, and our current systems are poorly designed for it. While procedural stamina may wane, late-career physicians gain the most critical assets: foresight, profound nuance, and

2/2: medical Rx vs.. Revascularization

Your diagnosis and what would you do next? ⁦@AbdullahAlabcha⁩

Congratulations to the newly matched @MayoCVFellows❤️‍🔥📚🩺! A remarkable new chapter awaits, with profound clinical moments, memorable wins, and mentorship that truly shapes careers. Excited to see your journeys unfold! Welcome to @MayoClinic @MayoClinicCV!

https://t.co/sqAvWtcFhX Sharing our latest piece on Valve intervention trials. Immense thanks to @MayraGuerreroMD for the support! @mandeep_mayo @MayoCVFellows @MayoClinicCV @AbdullahAlabcha

🌟Huge congrats to Dr. Abdullah Alabcha (@AbdullahAlabcha), Interventional Fellow @MayoClinic, handpicked as the inaugural Mayo Clinic CV/CRF Innovation Fellow. #AASC is proud to celebrate this milestone for leaders advancing cardiac medicine in our community. @adnanalkhouli

🗞️ Hot off the press: #STAR trial First randomized controlled trial comparing two different technical strategies in #CTO #PCI https://t.co/ufJNmNbO2e

Latest in #JACCINT: Among #AFib patients with ESRD, #LAAO showed lower rates of #stroke ⚡ major bleeding 💧 and death ☠️ compared with apixaban 💊 or warfarin, highlighting LAAO as a promising strategy! https://t.co/3CwoB3RWO7 @adnanalkhouli @AbdullahAlabcha

New in #JACCINT: 1-year results from the #CLASPIID trial show #MTEER benefits patients with degenerative MR across all cardiac damage stages 💪 Significant MR & #QoL improvements 🌟 low adverse events ⚡ and low mortality https://t.co/Rnkn21W9AP #vhdMR #TEER @AbdullahAlabcha

Wonderful news and a great collaboration between @MayoClinicCV and @crfheart

Wow! Blown away, so proud of my fellows!!!!

Delighted to announce the inaugural fellow for the Mayo Clinic CV/CRF Innovation Mentorship Program — Abdullah Al-Abcha. Co-chaired by @jgranadacrf and myself, this immersive experience will provide Dr. Alabcha with focused, hands-on exposure to MedTech innovation and the full

📢 New in @Heart_BMJ : Natural history of asymptomatic moderate/severe AR is more serious than traditionally believed. Key findings from our systematic review/meta-analysis of 4,720 patients led by super 🌟 @Jwan_Naser 🔹 Excess mortality: Annual all-cause mortality 1.75% —

Congratulations @AbdullahAlabcha for this important analysis showing the benefit of mTEER with pascal in patients with primary MR in all stages of extra-mitral cardiac damage, even Stage 4! With the safety of mTEER, it seems that it is never too late to intervene. A big thank you

Check out our #JACCINT analysis reporting outcomes of #MTEER in #degenerative #MR according to cardiac damage stages .. a post hoc analysis of the #CLASPIID trial🫀 Tremendously grateful for @MayraGuerreroMD mentorship and support https://t.co/9XrNYYxgI4 @JACCJournals #CardioX

#TCT2025: The effectiveness and safety of a planned investment procedure in high-risk chronic total occlusions - INVEST CTO 🔗 https://t.co/96NjA9MViS @KVM83 and @sof_pap14 provide an in-depth review ✍️of this single arm study presented by @AnjaKsnes in San Francisco.

Incredible weekend at #TCT2025! Grateful to be able to present our center's experience with novel approaches to coronary aneurysm management, and to be named among the best in show! Thankful to @rajivxgulati for his innovation and mentorship

In this study @JACCJournals, we find: 💡Prevalence of #TR ⬆️ in #HFpEF with PVR > with PAWP due to ⬆️ V-STR 💡None of noncardiac dyspnea pts had grades III/IV TR 💡V-STR is > A-STR, but atrial myopathy is prevalent 💡TR type stratifies outcome risk https://t.co/LJQHczs7VN

Check out our accompanying #editorial in #JACCINT👇🏽 Trust at 1:00 am: Integrating #AI Into #STEMI Decision-Making https://t.co/rdner1rCRs #CardioX #ACCFIT @JACCJournals @adnanalkhouli